411
Views
9
CrossRef citations to date
0
Altmetric
Articles

Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences

, , , , , , , & show all

References

  • Allen, N. L., E. W. Karlson, S. Malspeis, B. Lu, C. E. Seidman, and L. S. Lehmann. 2014. Biobank participants' preferences for disclosure of genetic research results: Perspectives from the OurGenes, OurHealth, OurCommunity project. Mayo Clinic Proceedings 89 (6):738–46. doi:10.1016/j.mayocp.2014.03.015.
  • Amendola, L. M., M. Horike-Pyne, S. B. Trinidad, S. M. Fullerton, B. J. Evans, W. Burke, and G. P. Jarvik. 2015. Patients' choice for return of exome sequencing results to relatives in the event of their death. Journal of Law, Medicine & Ethics 43 (3):476–85.
  • Aronowitz, R. 2015. Risky medicine: Our quest to cure fear and uncertainty. Chicago: University of Chicago Press.
  • Arribas-Ayllon, M., K. Featherstone, and P. Atkinson. 2011. The practical ethics of genetic responsibility: Non-disclosure and the autonomy of affect. Social Theory & Health 9 (1):3–23. doi:10.1057/sth.2009.22.
  • Atkinson, P., K. Featherstone, and M. Gregory. 2013. Kinscapes, timescapes and genescapes: Families living with genetic risk. Sociology of Health & Illness 35 (8):1227–41. doi:10.1111/1467-9566.12034.
  • Benner, P. E. 1994. Interpretive phenomenology: Embodiment, caring and ethics in health and illness. Thousand Oaks, CA: SAGE Publications.
  • Bennette, C. S., S. B. Trinidad, S. M. Fullerton, D. Patrick, L. Amendola, W. Burke, F. M. Hisama, G. P. Jarvik, D. A. Regier, and D. L. Veenstra. 2013. Return of incidental findings in genomic medicine: Measuring what patients value–development of an instrument to measure preferences for information from next-generation testing. Genetics in Medicine 15 (11):873–81. doi:10.1038/gim.2013.63.
  • Berg, J. S., M. J. Khoury, and J. P. Evans. 2011. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genetics in Medicine 13 (6):499–504. doi:10.1097/GIM.0b013e318220aaba.
  • Bergner, A. L., J. Bollinger, K. S. Raraigh, C. Tichnell, B. Murray, C. L. Blout, A. B. Telegrafi, and C. A. James. 2014. Informed consent for exome sequencing research in families with genetic disease: The emerging issue of incidental findings. American Journal of Medical Genetics Part A 164A (11):2745–52. doi:10.1002/ajmg.a.36706.
  • Beskow, L. M., and W. Burke. 2010. Offering individual genetic research results: Context matters. Science Translational Medicine 2 (38):38cm20. doi:10.1126/scitranslmed.3000952.
  • Beskow, L. M., E. E. Namey, R. J. Cadigan, T. Brazg, J. Crouch, G. E. Henderson, M. Michie, D. K. Nelson, H. K. Tabor, and B. S. Wilfond. 2011. Research participants' perspectives on genotype-driven research recruitment. Journal of Empirical Research on Human Research Ethics 6 (4):3–20. doi:10.1525/jer.2011.6.4.3.
  • Boenink, M., and S. van der Burg. 2010. Informed decision making about predictive DNA tests: Arguments for more public visibility of personal deliberations about the good life. Medicine, Health Care and Philosophy 13 (2):127–38. doi:10.1007/s11019-009-9227-6.
  • Bollinger, J. M., J. Scott, R. Dvoskin, and D. Kaufman. 2012. Public preferences regarding the return of individual genetic research results: Findings from a qualitative focus group study. Genetics in Medicine 14 (4):451–7. doi:10.1038/gim.2011.66.
  • Bredenoord, A. L., and J. J. M. van Delden. 2012. Disclosing individual genetic research results to deceased participants’ relatives by means of a qualified disclosure policy. American Journal of Bioethics 12 (10):10–12. doi:10.1080/15265161.2012.699145.
  • Burke, W., P. Appelbaum, L. Dame, P. Marshall, N. Press, R. Pyeritz, R. Sharp, and E. Juengst. 2015. The translational potential of research on the ethical, legal, and social implications of genomics. Genetics in Medicine 17 (1):12–20. doi:10.1038/gim.2014.74.
  • Chaffee, K. G., A. L. Oberg, R. R. McWilliams, N. Majithia, B. A. Allen, J. Kidd, N. Singh, A. R. Hartman, R. J. Wenstrup, and G. M. Petersen. 2018. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genetics in Medicine 20 (1):119–127. doi:10.1038/gim.2017.85.
  • Chan, B., F. M. Facio, H. Eidem, S. C. Hull, L. G. Biesecker, and B. E. Berkman. 2012. Genomic inheritances: Disclosing individual research results from whole-exome sequencing to deceased participants' relatives. American Journal of Bioethics 12 (10):1–8. doi:10.1080/15265161.2012.699138.
  • Clarke, A., L. Mamo, R. J. Fosket, J. R. Fishman, and J. K. Shim. 2010. Biomedicalization: Technoscience, health, and illness in the U.S. Durham, NC: Duke University Press.
  • Clayton, E. W., and S. E. Kelly. 2013. Let us ask better questions. Genetics in Medicine 15 (11):871–872. doi:10.1038/gim.2013.68.
  • Couzin-Frankel, J. 2014. Divulging DNA secrets of dead stirs debate. Science 343 (6169):356–357. doi:10.1126/science.343.6169.356.
  • Crawford, R. 1980. Healthism and the medicalization of everyday life. International Journal of Health Services: Planning, Administration, Evaluation 10 (3):365–88.
  • Dheensa, S., A. Fenwick, and A. Lucassen. 2016. Is this knowledge mine and nobody else's? I don't feel that. Patient views about consent, confidentiality and information-sharing in genetic medicine. Journal of Medical Ethics 42(3):174–79. doi:10.1136/medethics-2015-102781.
  • Dheensa, S., A. Fenwick, S. Shkedi-Rafid, G. Crawford, and A. Lucassen. 2015. Health-care professionals' responsibility to patients' relatives in genetic medicine: A systematic review and synthesis of empirical research. Genetics in Medicine 18 (4):290–301. doi:10.1038/gim.2015.72.
  • Dumit, J. 2012. Drugs for life: How pharmaceutical companies define our health. Durham, NC: Duke University Press.
  • Esserman, L. J., I. M. Thompson, Jr., and B. Reid. 2013. Overdiagnosis and overtreatment in cancer: An opportunity for improvement. Journal of the American Medical Association 310(8):797–98. doi:10.1001/jama.2013.108415.
  • Facio, F. M., H. Eidem, T. Fisher, S. Brooks, A. Linn, K. A. Kaphingst, L. G. Biesecker, and B. B. Biesecker. 2013. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. European Journal of Human Genetics 21 (3):261–65. doi:10.1038/ejhg.2012.179.
  • Fernandez, C. V., E. Bouffet, D. Malkin, N. Jabado, C. O’Connell, D. Avard, B. M. Knoppers, M. Ferguson, K. M. Boycott, P. H. Sorensen, et al. 2014. Attitudes of parents toward the return of targeted and incidental genomic research findings in children. Genetics in Medicine 16 (8):633–40. doi:10.1038/gim.2013.201.
  • Geertz, C. 1973. The interpretation of cultures: Selected essays. London, UK: Fontana.
  • Gilbar, R., and J. Miola. 2015. One size fits all? On patient autonomy, medical decision-making, and the impact of culture. Medical Law Review 23 (3):375–99. doi:10.1093/medlaw/fwu032.
  • Graves, K. D., P. S. Sinicrope, J. B. McCormick, Y. Zhou, S. T. Vadaparampil, and N. M. Lindor. 2015. Public perceptions of disease severity but not actionability correlate with interest in receiving genomic results: Nonalignment with current trends in practice. Public Health Genomics 18 (3):173–83. doi:10.1159/000375479.
  • Green, R. C., J. S. Berg, W. W. Grody, S. S. Kalia, B. R. Korf, C. L. Martin, A. L. McGuire, R. L. Nussbaum, J. M. O’Daniel, K. E. Ormond., et al. 2013. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine 15 (7):565–74. doi:10.1038/gim.2013.73.
  • Hacking, I. 1990. The taming of chance. Cambridge: Cambridge University Press. doi:10.1086/ahr/97.1.157.
  • Hallowell, N., K. Alsop, M. Gleeson, A. Crook, L. Plunkett, D. Bowtell, G. Mitchell, Group Australian Ovarian Cancer Study, and M. A. Young. 2013. The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian ovarian cancer study. Genetics in Medicine 15 (6):458–65. doi:10.1038/gim.2012.154.
  • Hallowell, N., C. Foster, R. Eeles, A. Ardern-Jones, V. Murday, and M. Watson. 2003. Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. Journal of Medical Ethics 29 (2):74–79. discussion 80-83. doi:10.1136/jme.29.2.74.
  • Ho, A. 2009. They just don't get it!' when family disagrees with expert opinion. Journal of Medical Ethics 35 (8):497–501. doi:10.1136/jme.2008.028555.
  • Husedzinovic, A., D. Ose, C. Schickhardt, S. Frohling, and E. C. Winkler. 2015. Stakeholders' perspectives on biobank-based genomic research: Systematic review of the literature. European Journal of Human Genetics 23 (12):1607–14. doi:10.1038/ejhg.2015.27.
  • Jarvik, G. P., L. M. Amendola, J. S. Berg, K. Brothers, E. W. Clayton, W. Chung, B. J. Evans, J. P. Evans, S. M. Fullerton, C. J. Gallego, et al. 2014. Return of genomic results to research participants: The floor, the ceiling, and the choices in between. American Journal of Human Genetics 94 (6):818–26. doi:10.1016/j.ajhg.2014.04.009.
  • Johns, A. L., S. H. McKay, J. L. Humphris, M. Pinese, L. A. Chantrill, R. S. Mead, K. Tucker, L. Andrews, A. Goodwin, C. Leonard, H. A., et al. 2017. Lost in translation: Returning germline genetic results in genome-scale cancer research. Genome Medicine 9 (1):41. doi:10.1186/s13073-017-0430-4.
  • Johns, A. L., D. K. Miller, S. H. Simpson, A. J. Gill, K. S. Kassahn, J. L. Humphris, J. S. Samra, K. Tucker, L. Andrews, D. K. Chang, N., et al. 2014. Returning individual research results for genome sequences of pancreatic cancer. Genome Medicine 6 (5):42. doi:10.1186/gm558.
  • Juengst, E. T., M. A. Flatt, and R. A. Settersten. Jr. 2012. Personalized genomic medicine and the rhetoric of empowerment. Hastings Center Report 42(5):34–40. doi:10.1002/hast.65.
  • Kaufman, S. R. 2015. Ordinary medicine: Extraordinary treatments, longer lives, and where to draw the line. Durham, NC: Duke University Press.
  • Kleinman, A. 1997. Writing at the margin: Discourse between anthropology and medicine. Berkeley: University of California Press.
  • Knoppers, B. M., M. Deschênes, H. Z. Ma’n, and A. M. Tassé. 2013. Population studies: Return of research results and incidental findings policy statement. European Journal of Human Genetics 21 (3):245–247. doi:10.1038/ejhg.2012.152.
  • Koenig, B. A. 2001. Why not grant primacy to the family? American Journal of Bioethics 1 (3):33–34. doi:10.1162/152651601750417937.
  • Konrad, M. 2003. From secrets of life to the life of secrets: Tracing genetic knowledge as genealogical ethics in biomedical Britain. Journal of the Royal Anthropological Institute 9 (2):339–58. doi:10.1111/1467-9655.00153.
  • Konrad, M. 2005. Narrating the new predictive genetics: Ethics, ethnography, and science. Cambridge: Cambridge University Press.
  • Lock, M. 1998. Breast cancer: Reading the omens. Anthropology Today 14 (4):7–16. doi:10.2307/2783351.
  • Lucassen, A., and A. Hall. 2012. Consent and confidentiality in clinical genetic practice: Guidance on genetic testing and sharing genetic information. Clinical Medicine 12 (1):5–6. doi:10.7861/clinmedicine.12-1-5.
  • Lupton, D. 1995. The imperative of health: Public health and the regulated body. London, UK: SAGE Publications.
  • Mackley, M. P., B. Fletcher, M. Parker, H. Watkins, and E. Ormondroyd. 2017. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: A systematic review of quantitative and qualitative studies. Genetics in Medicine 19 (3):283–93. doi:10.1038/gim.2016.109.
  • McGuire, A. L., T. Caulfield, and M. K. Cho. 2008. Research ethics and the challenge of whole-genome sequencing. Nature Reviews Genetics 9 (2):152–56. doi:10.1038/nrg2302.
  • McWilliams, R. R., W. R. Bamlet, M. de Andrade, D. N. Rider, J. M. Cunningham, and G. M. Petersen. 2009. Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiology, Biomarkers & Prevention 18 (4):1295–302. doi:10.1158/1055-9965.epi-08-1109.
  • McWilliams, R. R., G. M. Petersen, K. G. Rabe, L. M. Holtegaard, P. J. Lynch, M. D. Bishop, and W. E. Highsmith. Jr. 2010. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer 116 (1):203–9. doi:10.1002/cncr.24697.
  • Meulenkamp, T. M., S. K. Gevers, J. A. Bovenberg, G. H. Koppelman, A. V Hylckama Vlieg, and E. M. Smets. 2010. Communication of biobanks' research results: What do (potential) participants want? American Journal of Medical Genetics Part A 152A (10):2482–92. doi:10.1002/ajmg.a.33617.
  • Murphy, J., J. Scott, D. Kaufman, G. Geller, L. LeRoy, and K. Hudson. 2008. Public expectations for return of results from large-cohort genetic research. American Journal of Bioethics 8 (11):36–43. doi:10.1080/15265160802513093.
  • Nelkin, D., and M. S. Lindee. 1995. The DNA mystique: the gene as a cultural icon. New York: W. H. Freeman.
  • Nelson, A. M. 1997. Improving patient satisfaction now: How to earn patient and payer loyalty. Gaithersburg, MD: Aspen Publishers.
  • Parker, L. S. 2012. Returning individual research results: What role should people's preferences play? Minnesota Journal of Law, Science & Technology 13 (2):449–84.
  • Petersen, G. M., M. de Andrade, M. Goggins, R. H. Hruban, M. Bondy, J. F. Korczak, S. Gallinger, H. T. Lynch, S. Syngal, K. G. Rabe, D., et al. 2006. Pancreatic cancer genetic epidemiology consortium. Cancer, Epidemiology Biomarkers & Prevention 15 (4):704–10. doi:10.1158/1055-9965.EPI-05-0734.
  • Ploug, T., and S. Holm. 2017. Clinical genome sequencing and population preferences for information about 'incidental' findings: From medically actionable genes (MAGs) to patient actionable genes (PAGs). PLoS One 12 (7):e0179935. doi:10.1371/journal.pone.0179935.
  • Presidential Commission for the Study of Bioethical Issues. 2013. Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts. Washington, DC.
  • Press, N., J. R. Fishman, and B. A. Koenig. 2000. Collective fear, individualized risk: The social and cultural context of genetic testing for breast cancer. Nursing Ethics 7 (3):237–49. doi:10.1177/096973300000700306.
  • Radecki Breitkopf, C., G. M. Petersen, S. M. Wolf, K. G. Chaffee, M. E. Robinson, D. R. Gordon, N. M. Lindor, and B. A. Koenig. 2015. Preferences regarding return of genomic results to relatives of research participants, including after participant death: Empirical results from a cancer biobank. Journal of Law, Medicine & Ethics 43 (3):464–75. doi:10.1111/jlme.12289.
  • Radecki Breitkopf, C., G. M. Petersen, S. M. Wolf, K. G. Chaffee, M. E. Robinson, D. R. Gordon, N. M. Lindor, and B. A. Koenig. 2018. Attitudes toward return of genetic research results to relatives, including after death: Comparison of cancer probands, blood relatives, and spouse/partners. Journal of Empirical Research on Human Research Ethics 13 (3):295–304. doi:10.1177/1556264618769165.
  • Shindo, K., J. Yu, M. Suenaga, S. Fesharakizadeh, C. Cho, A. Macgregor-Das, A. Siddiqui, P. D. Witmer, K. Tamura, T. J. Song, J. A., et al. 2017. Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. Journal of Clinical Oncology 35 (30):3382–390. doi:10.1200/JCO.2017.72.3502.
  • Shkedi-Rafid, S., S. Dheensa, G. Crawford, A. Fenwick, and A. Lucassen. 2014. Defining and managing incidental findings in genetic and genomic practice. Journal of Medical Genetics 51 (11):715–23. doi:10.1136/jmedgenet-2014-102435.
  • Strauss, A. L., and J. M. Corbin. 1990. Basics of qualitative research: Grounded theory procedures and techniques. Newbury Park, CA: Sage Publications.
  • Timmermans, S., and M. Buchbinder. 2013. Saving babies? The consequences of newborn genetic screening, fieldwork encounters and discoveries. Chicago, IL: University of Chicago Press.
  • Weaver, M. 2016. The double helix: Applying an ethic of care to the duty to warn genetic relatives of genetic information. Bioethics 30 (3):181–87. doi:10.1111/bioe.12176.
  • Wertz, D. C., and J. C. Fletcher. 1991. Privacy and disclosure in medical genetics examined in an ethics of care. Bioethics 5 (3):212–32.
  • Wolf, S. M., Branum, R. B. A. Koenig, G. M. Petersen, S. A. Berry, L. M. Beskow, M. B. Daly, C. V. Fernandez, R. C. Green, B. S. LeRoy, N. M., et al. 2015. Returning a research participant's genomic results to relatives: Analysis and recommendations. Journal of Law, Medicine & Ethics 43 (3):440–63. doi:10.1111/jlme.12288.
  • Wolf, S. M., Crock, B. N. B. Van Ness, F. Lawrenz, J. P. Kahn, L. M. Beskow, M. K. Cho, M. F. Christman, R. C. Green, R. Hall, J., et al. 2012. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genetics in Medicine 14 (4):361–84. doi:10.1038/gim.2012.23.
  • Wolf, S. M., B. A. Koenig, and G. M. Petersen, eds. 2015. Symposium: Should we offer genomic research results to a participant's family, including after the participant's death? Journal of Law, Medicine & Ethics 43 (3):437–666.
  • Wolf, S. M., F. P. Lawrenz, C. A. Nelson, J. P. Kahn, M. K. Cho, E. Wright Clayton, J. G. Fletcher, M. K. Georgieff, D. Hammerschmidt, and K. Hudson. 2008. Managing incidental findings in human subjects research: Analysis and recommendations. The Journal of Law, Medicine & Ethics 36 (2):219–48. doi:10.1111/j.1748-720X.2008.00266.x.
  • Zerhouni, E. A. 2007. Translational research: Moving discovery to practice. Clinical Pharmacology & Therapeutics 81 (1):126–28. doi:10.1038/sj.clpt.6100029.
  • Zhen, D. B., K. G. Rabe, S. Gallinger, S. Syngal, A. G. Schwartz, M. G. Goggins, R. H. Hruban, M. L. Cote, R. R. McWilliams, N. J. Roberts, et al. 2015. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: A PACGENE study. Genetics in Medicine 17 (7):569–77. doi:10.1038/gim.2014.153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.